“Worldwide, roughly 300 million people have #asthma, and so far, all of our treatments have been aimed at symptomatic control. There hasn’t been much progress toward finding therapies that can induce disease remission” @ScienceTM https://t.co/xAkSd8HkfU …
RT @asthma_papers: Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2…
Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation. https://t.co/buHII03ROc